Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Menkes Disease Mutations And Response To Early Copper Histidine Treatment

S. Kaler
Published 1996 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references



This paper is referenced by
10.1007/s00424-020-02412-2
The molecular mechanisms of copper metabolism and its roles in human diseases
J. Chen (2020)
10.1016/J.YMGME.2007.01.010
Safety of intracerebroventricular copper histidine in adult rats.
K. Lem (2007)
10.1016/B978-0-12-411512-5.00011-7
Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
S. Kaler (2013)
10.1016/S0161-813X(01)00050-X
Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release.
E. Tiffany-Castiglion (2001)
10.1074/JBC.M208864200
Copper-regulated Trafficking of the Menkes Disease Copper ATPase Is Associated with Formation of a Phosphorylated Catalytic Intermediate*
M. Petris (2002)
10.1056/NEJMoa070613
Neonatal diagnosis and treatment of Menkes disease.
Stephen G. Kaler (2008)
10.1017/S0029665110003873
Risk-benefit analysis of mineral intakes: case studies on copper and iron.
S. Fairweather-Tait (2011)
10.1007/8904_2014_391
Tandem Duplication of Exons 1-7 Neither Impairs ATP7A Expression Nor Causes a Menkes Disease Phenotype.
Eun-Young Choi (2015)
10.1111/j.1399-0004.2005.00496.x
Copper‐replacement treatment for symptomatic Menkes disease: ethical considerations
S. R. Sheela (2005)
Diagnosis and therapy of Menkes syndrome , a genetic form of copper deficiency 1 , 2
S. Kaler ()
Modulating copper metabolism as a strategy to treat neurodegenerative tauopathies
S. McKenzie-Nickson (2017)
10.1007/s11011-017-0010-8
13 novel putative mutations in ATP7A found in a cohort of 25 Italian families
Paola de Gemmis (2017)
10.1093/HMG/8.8.1547
Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease.
L. Ambrosini (1999)
10.1016/S1054-3589(08)60697-3
Dopamine beta-hydroxylase deficiency associated with mutations in a copper transporter gene.
S. Kaler (1998)
10.1002/(SICI)1097-0223(199803)18:3<287::AID-PD352>3.0.CO;2-7
Prenatal diagnosis of Menkes disease
S. Kaler (1998)
10.1002/ANA.410410125
Early copper histidine therapy in classic menkes disease
B. Sarkar (1997)
10.1039/c6mt90022d
Copper comes of age in Melbourne.
J. Mercer (2016)
10.1111/j.1399-0004.2006.00596.x
Late‐onset treatment in Menkes disease: is there a correlation between genotype and response to therapy?
J. L. Olivares (2006)
10.1016/j.ymgme.2012.05.008
In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
Marie Reine Haddad (2012)
10.1093/HMG/6.7.1037
Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease.
A. Grimes (1997)
10.1086/505407
Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.
M. Paulsen (2006)
10.1016/j.jtemb.2014.07.008
Changes in body weight and height in survivors of Menkes disease.
Y. Gu (2014)
10.1074/JBC.273.6.3765
Functional Expression of the Menkes Disease Protein Reveals Common Biochemical Mechanisms Among the Copper-transporting P-type ATPases*
A. Payne (1998)
10.1016/S0014-5793(98)01059-X
ATP‐dependent copper transport by the Menkes protein in membrane vesicles isolated from cultured Chinese hamster ovary cells
I. Voskoboinik (1998)
10.1046/j.1471-4159.1996.67051781.x
Catecholamine Phenotyping: Clues to the Diagnosis, Treatment, and Pathophysiology of Neurogenetic Disorders
D. Goldstein (1996)
10.1007/978-1-59259-288-3_15
Molecular Basis of Diseases of Copper Homeostasis
J. Mercer (2002)
10.1073/PNAS.95.18.10854
Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.
A. Payne (1998)
10.1093/HMG/8.9.1665
Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.
O. I. Buiakova (1999)
10.1016/j.eplepsyres.2014.08.006
Epilepsy in Menkes disease: An electroclinical long-term study of 28 patients
A. Verrotti (2014)
10.1016/J.IJPORL.2007.02.021
Internal jugular phlebectasia in Menkes disease.
D. J. Price (2007)
10.1002/ana.21576
Translational read‐through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes disease
S. Kaler (2009)
Role of copper in human neurological disorders 1 – 3
V. Desai (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar